Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

5.06
Delayed Data
As of Jan 24
 -0.22 / -4.17%
Today’s Change
2.00
Today|||52-Week Range
25.20
-5.60%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 9.00. The median estimate represents a +107.51% increase from the last price of 5.06.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.66
Sales
$0.00
Reporting Date
Feb 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.97%
 
 
 
 
 
 
Growthannually 62.86%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.